Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 3
2014 2
2015 3
2016 2
2017 4
2018 4
2019 4
2020 4
2021 7
2022 11
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge.
Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, Friger M, Waxman JG, Dagan N, Balicer R, Ben-Shlomo Y, Peretz A, Yaron S, Serby D, Hammerman A, Netzer D. Arbel R, et al. Among authors: hammerman a. N Engl J Med. 2022 Sep 1;387(9):790-798. doi: 10.1056/NEJMoa2204919. Epub 2022 Aug 24. N Engl J Med. 2022. PMID: 36001529 Free PMC article.
Bivalent Boosters against Severe Omicron Infection.
Arbel R, Hammerman A, Netzer D. Arbel R, et al. Among authors: hammerman a. N Engl J Med. 2023 May 4;388(18):1726. doi: 10.1056/NEJMc2303753. N Engl J Med. 2023. PMID: 37133606 No abstract available.
Dapagliflozin versus empagliflozin in patients with chronic kidney disease.
Alnsasra H, Tsaban G, Solomon A, Khalil F, Aboalhasan E, Azab AN, Azuri J, Hammerman A, Arbel R. Alnsasra H, et al. Among authors: hammerman a. Front Pharmacol. 2023 Aug 4;14:1227199. doi: 10.3389/fphar.2023.1227199. eCollection 2023. Front Pharmacol. 2023. PMID: 37601066 Free PMC article.
BNT162b2 Vaccine Booster and Covid-19 Mortality. Reply.
Arbel R, Sergienko R, Hammerman A. Arbel R, et al. Among authors: hammerman a. N Engl J Med. 2022 Mar 10;386(10):1000-1001. doi: 10.1056/NEJMc2120044. Epub 2022 Feb 9. N Engl J Med. 2022. PMID: 35139268 No abstract available.
Nirmatrelvir Use during the Omicron Surge. Reply.
Arbel R, Wolff Sagy Y, Hammerman A. Arbel R, et al. Among authors: hammerman a. N Engl J Med. 2022 Dec 29;387(26):2480-2481. doi: 10.1056/NEJMc2213868. N Engl J Med. 2022. PMID: 36577109 No abstract available.
Risk assessment of human mpox infections: retrospective cohort study.
Zucker R, Lavie G, Wolff-Sagy Y, Gur-Arieh N, Markovits H, Abu-Ahmad W, Battat E, Ramot N, Beckenstein T, Carmeli G, Mark-Amir A, Wagner-Kolasko G, Edry A, Duskin-Bitan H, Yaron S, Peretz A, Hammerman A, Netzer D, Arbel R. Zucker R, et al. Among authors: hammerman a. Clin Microbiol Infect. 2023 Aug;29(8):1070-1074. doi: 10.1016/j.cmi.2023.04.022. Epub 2023 Apr 25. Clin Microbiol Infect. 2023. PMID: 37105439 Free PMC article.
Real-world effectiveness of a single dose of mpox vaccine in males.
Wolff Sagy Y, Zucker R, Hammerman A, Markovits H, Arieh NG, Abu Ahmad W, Battat E, Ramot N, Carmeli G, Mark-Amir A, Wagner-Kolasko G, Duskin-Bitan H, Yaron S, Peretz A, Arbel R, Lavie G, Netzer D. Wolff Sagy Y, et al. Among authors: hammerman a. Nat Med. 2023 Mar;29(3):748-752. doi: 10.1038/s41591-023-02229-3. Epub 2023 Jan 31. Nat Med. 2023. PMID: 36720271 Free PMC article.
Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.
Hammerman A, Sergienko R, Friger M, Beckenstein T, Peretz A, Netzer D, Yaron S, Arbel R. Hammerman A, et al. N Engl J Med. 2022 Mar 31;386(13):1221-1229. doi: 10.1056/NEJMoa2119497. Epub 2022 Feb 16. N Engl J Med. 2022. PMID: 35172072 Free PMC article.
59 results